Complex Made Simple

Hikma Pharmaceuticals posts H1 revenue results

Jordan's Hikma Pharmaceuticals has posted a 10.4% rise in first-half revenue thanks to strong sales in Algeria, Sudan and Iraq, Reuters has reported. Despite problems in other North African and Middle East markets, the Amman-based company reported sales in the first six months of 2011 of $394.8m. The company's operating profit of $49m was 34% less than a year ago, reflecting lower margins due to loss of some high-profit lines.